eTheRNA immunotherapies & Frame Therapeutics collaboration is awarded EUR 1.9 million Eurostars research grant to develop novel cancer vaccines
Amsterdam (Netherlands) and Niel (Belgium) A collaborative project between eTheRNA immunotherapies NV and Frame Therapeutics has been awarded a Eurostars grant totalling EUR 1.9 million for the development of a therapeutic vaccine for the treatment of kidney cancer. The Eurostars program aims to stimulate partnerships between European SMEs and start-ups to foster international collaboration and development of innovative technologies.